抗血栓薬/抗凝固薬の世界市場は、2023年から2028年まで7.9%のCAGRで成長し、2023年の316億ドルから2028年までに462億ドルに達する見込みです。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Research Methodology
Information Sources
Geographic Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Summary
Chapter- 3: Market Overview
Overview of Cardiovascular Disease
Major Drivers
Chapter- 4: Global Market for Anticoagulant Drugs
Overview
Products
Global Anticoagulant Drugs Market Forecast
Chapter- 5: Global Market for Antiplatelet Drugs
Overview
Products
Global Antiplatelet Drugs Market Forecast
Chapter- 6: Global Market for Thrombin Inhibitors
Overview
Products
Global Thrombin Inhibitors Market Forecast
Chapter- 7: Global Market for Antithrombotic/Anticoagulant Drugs by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 8: Sustainability in the Market for Antithrombotic/Anticoagulant Drugs: An ESG Perspective
Introduction to ESG
Sustainability in Market for Antithrombotic/Anticoagulant Drugs: An ESG Perspective
Consumer Attitudes Towards ESG
Industry ESG Performance Analysis
Case Study
Concluding Remarks from BCC
Chapter- 9: Clinical Trials and Patent Landscape
Clinical Trials Analysis
Patent Analysis
Chapter- 10: M&A and Venture Funding Outlook
M&A Analysis
Chapter- 11: Competitive Landscape
Table 63 : Global Market for Antithrombotic/Anticoagulant Drugs Revenue Analysis, 2022
Figure 16 : Global Market Shares of Antithrombotic/Anticoagulant Drugs, by Company, 2022
Table 64 : Global Market for Antithrombotic/Anticoagulant Drugs Key Product Portfolio, 2022
Table 65 : Global Thrombin Inhibitors Drugs Market Revenue Analysis, 2022
Figure 17 : Global Market Shares of Thrombin Inhibitors Drugs, by Company, 2022
Table 66 : Global Anticoagulants Drug Market Revenue Analysis, 2022
Figure 18 : Global Market Shares of Anticoagulant Drugs, by Company, 2022
Table 67 : Global Antiplatelet Drugs Market Revenue Analysis, 2022
Figure 19 : Global Market Shares of Antiplatelet Drugs, by Company, 2022
Chapter- 12: Company Profiles
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL MYERS SQUIBB
DAIICHI SANKYO CO. LTD.
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
PFIZER INC.
SANOFI
Chapter- 13: Appendix
Government Regulatory Agencies and Professional Organizations